Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
Arthritis and Rheumatism|November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.
HGG Advances|September 18, 2023
BRCA1 frameshift variants leading to extended incorrect protein C terminiThales C Nepomuceno, Tzeh Keong Foo, Marcy E Richardson, et al.
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.
Rheumatology (Oxford, England)|June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.
Arthritis and Rheumatism|November 18, 2000
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trialP J Clements, E L Hurwitz, W K Wong, et al.
Arthritis and Rheumatism|March 27, 2001
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trialP J Clements, W K Wong, E L Hurwitz, et al.
BMC Genomics|November 1, 2015
Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strainsJohn J Varga, Mariette Barbier, Xavier Mulet, et al.
Annals of the Rheumatic Diseases|March 17, 2006
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine studyD Khanna, D E Furst, R D Hays, et al.
Arthritis and Rheumatism|April 29, 1998
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind studyF M Wigley, J H Korn, M E Csuka, et al.
Scandinavian Journal of Rheumatology|October 10, 2017
There is a need for new systemic sclerosis subset criteria. A content analytic approachS R Johnson, M L Soowamber, J Fransen, et al.
Pageof 34